Cardiac Monitoring & Cardiac Rhythm Management Market by Product (Cardiac Monitoring Devices, Cardiac Rhythm Management Devices), End-User (Ambulatory Center, Home Healthcare, Hospitals) - Global Forecast 2024-2030

Cardiac Monitoring & Cardiac Rhythm Management Market by Product (Cardiac Monitoring Devices, Cardiac Rhythm Management Devices), End-User (Ambulatory Center, Home Healthcare, Hospitals) - Global Forecast 2024-2030


The Cardiac Monitoring & Cardiac Rhythm Management Market size was estimated at USD 45.71 billion in 2023 and expected to reach USD 51.54 billion in 2024, at a CAGR 12.86% to reach USD 106.65 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Cardiac Monitoring & Cardiac Rhythm Management Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Cardiac Monitoring & Cardiac Rhythm Management Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Cardiac Monitoring & Cardiac Rhythm Management Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, ACS Diagnostics by Applied Cardiac Systems Inc., Alivecor, Inc., Asahi Kasei Corporation, Baxter International Inc., Biotronik SE & Co KG, Boston Scientific Corporation, BPL Medical Technologies Private Limited, GE Healthcare, HeartFlow Holding, Inc., Koninklijke Philips N.V.,, Lepu Medical Technology(Beijing)Co.,Ltd., Medtronic PLC, Microport Scientific Corporation, Nihon Kohden Corporation, Qardio, Inc., Schiller AG, Spandan, Tricog Health, and Zoll Medical Corporation.

Market Segmentation & Coverage


This research report categorizes the Cardiac Monitoring & Cardiac Rhythm Management Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product
Cardiac Monitoring Devices
ECG
Holter Monitors

Resting ECG

Stress ECG

Echocardiogram

Event Monitors

Implantable Loop Recorders

Mobile Cardiac Telemetry
Cardiac Rhythm Management Devices
Defibrillators
External Defibrillator
Automatic External Defibrillator

Manual External Defibrillator

Wearable Cardioverter Defibrillator

Implantable Cardioverter Defibrillators
S-ICD

T-ICD

Loop Recorders

Pacemaker
External

Implantable
End-User
Ambulatory Center
Home Healthcare
Hospitals
Region
Americas
Argentina

Brazil

Canada

Mexico

United States
California

Florida

Illinois

New York

Ohio

Pennsylvania

Texas
Asia-Pacific
Australia

China

India

Indonesia

Japan

Malaysia

Philippines

Singapore

South Korea

Taiwan

Thailand

Vietnam
Europe, Middle East & Africa
Denmark

Egypt

Finland

France

Germany

Israel

Italy

Netherlands

Nigeria

Norway

Poland

Qatar

Russia

Saudi Arabia

South Africa

Spain

Sweden

Switzerland

Turkey

United Arab Emirates

United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Cardiac Monitoring & Cardiac Rhythm Management Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Cardiac Monitoring & Cardiac Rhythm Management Market?
3. What are the technology trends and regulatory frameworks in the Cardiac Monitoring & Cardiac Rhythm Management Market?
4. What is the market share of the leading vendors in the Cardiac Monitoring & Cardiac Rhythm Management Market?
5. Which modes and strategic moves are suitable for entering the Cardiac Monitoring & Cardiac Rhythm Management Market?

Note: PDF & Excel + Online Access - 1 Year


1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Cardiac Monitoring & Cardiac Rhythm Management Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing geriatric population and incidence of cardiovascular diseases
5.1.1.2. Favorable government regulations and availability of reimbursement for CRM
5.1.1.3. Growing awareness towards early diagnosis and preventive healthcare measures
5.1.2. Restraints
5.1.2.1. High cost associated with cardiac monitoring and rhythm management devices
5.1.3. Opportunities
5.1.3.1. Increasing proclivity for wearable cardiac monitoring devices
5.1.3.2. Ongoing development for advanced cardiac devices
5.1.4. Challenges
5.1.4.1. Lack of skilled professionals with expertise in electrocardiography and cardiac rhythm
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Cardiac Monitoring & Cardiac Rhythm Management Market, by Product
6.1. Introduction
6.2. Cardiac Monitoring Devices
6.3.1. ECG
6.3.2.1. Holter Monitors
6.3.2.2. Resting ECG
6.3.2.3. Stress ECG
6.3.2. Echocardiogram
6.3.3. Event Monitors
6.3.4. Implantable Loop Recorders
6.3.5. Mobile Cardiac Telemetry
6.3. Cardiac Rhythm Management Devices
6.4.1. Defibrillators
6.4.2.1. External Defibrillator
6.4.2.2.1. Automatic External Defibrillator
6.4.2.2.2. Manual External Defibrillator
6.4.2.2.3. Wearable Cardioverter Defibrillator
6.4.2.2. Implantable Cardioverter Defibrillators
6.4.2.3.1. S-ICD
6.4.2.3.2. T-ICD
6.4.2. Loop Recorders
6.4.3. Pacemaker
6.4.4.1. External
6.4.4.2. Implantable
7. Cardiac Monitoring & Cardiac Rhythm Management Market, by End-User
7.1. Introduction
7.2. Ambulatory Center
7.3. Home Healthcare
7.4. Hospitals
8. Americas Cardiac Monitoring & Cardiac Rhythm Management Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. Asia-Pacific Cardiac Monitoring & Cardiac Rhythm Management Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam
10. Europe, Middle East & Africa Cardiac Monitoring & Cardiac Rhythm Management Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom
11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.2. Market Share Analysis, By Key Player
11.3. Competitive Scenario Analysis, By Key Player
12. Competitive Portfolio
12.1. Key Company Profiles
12.1.1. Abbott Laboratories
12.1.2. ACS Diagnostics by Applied Cardiac Systems Inc.
12.1.3. Alivecor, Inc.
12.1.4. Asahi Kasei Corporation
12.1.5. Baxter International Inc.
12.1.6. Biotronik SE & Co KG
12.1.7. Boston Scientific Corporation
12.1.8. BPL Medical Technologies Private Limited
12.1.9. GE Healthcare
12.1.10. HeartFlow Holding, Inc.
12.1.11. Koninklijke Philips N.V.,
12.1.12. Lepu Medical Technology(Beijing)Co.,Ltd.
12.1.13. Medtronic PLC
12.1.14. Microport Scientific Corporation
12.1.15. Nihon Kohden Corporation
12.1.16. Qardio, Inc.
12.1.17. Schiller AG
12.1.18. Spandan
12.1.19. Tricog Health
12.1.20. Zoll Medical Corporation
12.2. Key Product Portfolio
13. Appendix
13.1. Discussion Guide
13.2. License & Pricing
FIGURE 1. CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET RESEARCH PROCESS
FIGURE 2. CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, 2023 VS 2030
FIGURE 3. CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET DYNAMICS
FIGURE 7. CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 10. CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. AMERICAS CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 12. AMERICAS CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. UNITED STATES CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 14. UNITED STATES CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. ASIA-PACIFIC CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. ASIA-PACIFIC CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 20. CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SHARE, BY KEY PLAYER, 2023

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings